| For: | Abdelwahab MM, Ghattas AS, Tawheed A. Implications of gut microbiota in hepatic and pancreatic diseases: Gut-liver-pancreas axis. World J Hepatol 2025; 17(9): 109965 [PMID: 41024883 DOI: 10.4254/wjh.v17.i9.109965] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i9/109965.htm |
| Number | Citing Articles |
| 1 |
Yi Zhang, Haixin Ding, Xue Zhao, Yutong Li, Pengling Ge. The immunometabolic network in obesity-associated insulin resistance: a systemic multi-organ and multi-cellular perspective. International Immunopharmacology 2026; 177 doi: 10.1016/j.intimp.2026.116528
|
| 2 |
Hao-Yao Pan, Wei-Wei Chen, Jia-Xin Liang, Yi-Yang Sheng, Wen-Jing Zhang, Xue-Wen Zhu, Shuai-Yan Wang, Guan-Hu Yang, Yun Liu, Tian-Cheng Xu. Pancreatic-liver crosstalk, novel molecular mediators, and 2025 therapeutic breakthroughs. World Journal of Methodology 2026; 16(3): 118728 doi: 10.5662/wjm.v16.i3.118728
|
| 3 |
Ruodi Yang, Shichao Zhang, Zishan Fu, Yufeng Yang, Qingfeng Wang, Ying Zhou, Jiaxin Li, Ruisi Yang, Shunyu Ning, Yan Shi, Juntong Liu. Targeting the Gut Microbiota‐Metabolism Axis: Novel Pharmacological Mechanisms and Translational Application Strategies for Oral Antidiabetic Drugs. Medicinal Research Reviews 2026; doi: 10.1002/med.70117
|